Quantori

Quantori is at the forefront of transforming drug discovery with a unique value proposition that combines deep scientific domain knowledge with data science and advanced analytics expertise, and software engineering excellence. Our mission is to help biopharma companies speed up discovery of viable drug candidates to deliver new therapies to patients worldwide and optimize treatments for precision healthcare.

Principal and Chief Scientific Officer

Felicitex Therapeutics Inc.

Founder & board member of therapeutics company that develops novel treatments for dormant cancers - targeting resistance, metastasis, and relapse. Felicitex therapies specifically target and kill cancer cells that use the dormancy state for their survival niche.

Cofounder, Scientific Advisory and Board of Directors

EPAM Systems

Joined EPAM as a result of the acquisition of GGA Software Services. Led business development, account and delivery management, and provision of consulting services to clients of EPAM's Life Sciences business unit.

Chief Life Sciences Officer and Vice President

GGA Software Services

Founded leading provider of scientific software engineering, algorithm development, and knowledge management solutions for the life sciences industry.  Led financial planning, business development, client and delivery management. Managed cross-border team of 300 scientists, software engineers and algorithm developers.

Founder and Chief Scientific Officer

Elsevier

Joined Executive Team after Elsevier acquired ITC. Directed scientific content curation and analysis programs.

Director - Content Database Development

Institute of Theoretical Chemistry (ITC)

Founded research firm that developed bespoke client solutions based on theoretical chemistry. Led research, product, and business development and supervised 100-person team of scientific research and development professionals.

Founder, Co-Owner

Houghton Mifflin Harcourt

Joined Harcourt Management Team as a result of the acquisition of SciVision. Managed 150-person team developing scientific information systems.

Director - Information Systems

SciVision, Inc.

Founded company focused on developing software solutions for modeling of physicochemical properties of proteins and small molecules.

Founder, Director

Institute of Silicate Chemistry of RAS

Conducted experimental research and developed mathematical models for optimizing the properties of glass.

Scientist

Yuriy Gankin, Ph.D., is a life science researcher, serial entrepreneur, and inventor who has over two decades of expertise in helping life sciences, biotech and pharma companies develop IT solutions for accelerating the discovery and development of novel therapies which treat disease and improve the quality of patient lives.

He currently serves as Principal and Chief Scientific and Strategy Officer at Quantori, a developer of intelligent IT and data science solutions for life sciences, pharma, and healthcare organizations. Quantori is at the forefront of transforming drug discovery and healthcare with a unique value proposition that combines advanced analytics, scientific knowledge management, and software engineering excellence.

Previously, Dr. Gankin was Chief Life Sciences Officer and Vice President of the Life Sciences Business Unit at EPAM, following the acquisition of GGA Software Services by EPAM.  As the cofounder of GGA, he helped build the company into a leading provider of scientific software engineering, algorithm development, and data curation services.

Dr. Gankin's research has been published in multiple scientific journals and he holds several patents for targeted cancer therapy. His expertise spans research, database development, and modeling in chemistry and biology. Dr. Gankin holds a Ph.D. in Analytical Chemistry from Tufts University where he is a Visiting Scientist, in addition to an MBA from MIT Sloan.

Big thanks to the DCI Network organizing committee for inviting Quantori to the “Signal Through The Noise: What Works, What Lasts, and What Matters in Healthcare AI” conference on September 25.

The event kicked off with inspiring remarks from Yuri Quintana, PhD, FACMI, FIAHSI, and Steve Labkoff, MD’s powerful metaphor about finding “signal through the noise,” like a photographer revealing galaxies hidden in the night sky, resonated with me.

It was great to see the presentation from Alexander Petrov and Dr. Avijit Chatterjee on “DeepLIIF: An AI-Driven Open Source Pathology System”, developed at the Nadeem Lab at MSKCC. The project exemplifies how AI innovation can drive meaningful social impact: through the DP4All initiative, doctors in underserved regions can access advanced diagnostic tools to improve patient outcomes.

Quantori is proud to be MSKCC’s development partner, contributing our expertise to advance open and impactful HCLS AI/ML solutions.

Learn more:
DeepLIIF project: https://deepliif.org/
Presentation recording: https://lnkd.in/eqwWQBpP
Astrophotography photo credit: Steve Labkoff, MD

#AIplatform #DeepLIIF #AIML #Lifesciences

Yuriy Gankin, PhD

Principal and Chief Scientific Officer at Quantori

taplio

Yuriy Gankin, PhD's Linkedin Analytics

Yuriy Gankin, PhD

Performance ScoreYuriy Gankin, PhD's LinkedIn Performance

Yuriy Gankin, PhD's Best Posts (last 30 days)

Ready to grow your LinkedIn presence?

taplio

.css-6ytdur{background-image:linear-gradient(284deg, rgba(39, 43, 72, 1) 0%, rgba(33, 47, 183, 1) 100%);color:transparent;-webkit-background-clip:text;background-clip:text;}Yuriy Gankin, PhD's Linkedin Analytics

Yuriy Gankin, PhD

Performance Score.css-goub6s{font-size:var(--chakra-fontSizes-md);font-weight:500;color:var(--chakra-colors-gray-600);display:block;margin-top:var(--chakra-space-1);}Yuriy Gankin, PhD's LinkedIn Performance

Yuriy Gankin, PhD's Best Posts .css-1emoo84{font-size:var(--chakra-fontSizes-md);font-weight:400;color:var(--chakra-colors-gray-600);}(last 30 days)

Ready to grow your LinkedIn presence?

Yuriy Gankin, PhD's Linkedin Analytics

Performance ScoreYuriy Gankin, PhD's LinkedIn Performance

Yuriy Gankin, PhD's Best Posts (last 30 days)